medigraphic.com
Instituto Nacional de Salud Pública

2007, Number S2

<< Back Next >>

salud publica mex 2007; 49 (S2)

Use of Geographical Information Systems for billboards and points-of-sale surveillance in two Mexico cities

Hernández-Ávila JE, Tirado-Ramírez E, Santos-Luna R, Reynales-Shigematsu LM

Language: English
References: 53
Page: 241-246
PDF size: 308.79 Kb.


ABSTRACT

Objective. To assess the degree of compliance with current legislation using Geographic Information Systems. Material and Methods. Schools and billboards advertising tobacco were geo-referenced and the distance to schools were measured. Students’ access to purchasing tobacco products was observed. Results. In Cuernavaca, billboards were found within 250 meter from schools and students had access to buying cigarettes. In Culiacan, students were less exposed to tobacco advertising. Conclusions. Geographic Information Systems were useful for studying compliance with the law and could also be useful for its continuous monitoring and for suggesting changes for diminishing tobacco advertising exposure. This exposure and the ease of access to purchasing cigarettes could explain the higher prevalence of active smokers among students in Cuernavaca. This suggests that current legislation is still not enough enforced for diminishing Mexican adolescents’ exposure to tobacco advertising and products.


REFERENCES

  1. Valdés-Salgado R, Thrasher J, Sánchez-Zamorano LM, Lazcano-Ponce E, Reynales-Shigematsu LM, Meneses-González F, et al. Los retos del convenio marco para el control del tabaco en México: un diagnóstico a partir de la Encuesta sobre Tabaquismo en Jóvenes. Salud Publica Mex 2006;48:5-16.

  2. Campuzano-Rincón JC, Hernández-Avila M, Sammet JM, Méndez- Ramírez I, Tapia-Conyer R, Sepúlveda-Amor J. Comportamiento de los fumadores en México según las Encuestas Nacionales de Adicciones 1988 a 1998. In: Valdés-Salgado R, Lazcano-Ponce EC, Hernández-Avila M. Primer informe sobre el combate al tabaquismo. México ante el Convenio Marco para el Control del Tabaco, México. Cuernavaca: Instituto Nacional de Salud Pública, 2005.

  3. Breslau N, Peterson EL. Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 1996;86:214-220.

  4. Ricketts TC. Geographic information systems and public health. Ann Rev Public Health 2003;24:1-6.

  5. Cromley HK, McLafferty SL. GIS and public health. New York:Guilford, 2002;15-38.

  6. Hernández-Avila JE, Rodríguez MH, Rodríguez NE, Santos R, Morales E, Cruz C, et al. Cobertura geográfica del sistema mexicano de salud y análisis espacial de la utilización de hospitales generales de la Secretaría de Salud en 1998. Salud Publica Mex 2002;44:519-532.

  7. McLafferty SL. GIS and health care. Ann Rev Public Health 2003;24:25-42.

  8. Luke D, Esmundo E, Bloom Y. Smoke signs: patterns of tobacco billboard advertising in a metropolitan region. Tob Control 2000;9:16-23.

  9. Brody J, Melly S, Rudel R, Maxwell N. GIS exposure assessment for pesticides and drinking water in the Cape Cod breast cancer and environment study. Epidemiology 2000;11:102.

  10. Josef C, Matthias H, Ulrike G, Hoek G, Diegmann V, Brunekreef B, et al. GIS-based estimation of exposure to particulate matter and NO2 in an urban area: Stochastic versus dispersion modeling. Environ Health Perspect 2005; 113: 987-992.

  11. Ponciano RG. Conceptos actuales sobre tabaquismo. México: Trillas, 2007. Documento inédito.

  12. Peto R, López A, Boreham J, Thun M. Mortality from smoking in developed countries 1950-2000. 2a. edición. Oxford: Oxford University Press, 2004.

  13. World Health Organization. Tobacco: deadly in any form or disguise. World non tobacco day 2006. [Consultada el 31 de marzo de 2007]. Disponible en: www.who.int/tobacco/wntd.

  14. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years observations on male British doctors. Br Med J 1994;309(6959):901-911.

  15. Twigg L, Moon G , Walker S. The smoking epidemic in England. London: Health Development Agency, 2004.

  16. World Health Organization. Tobacco free initiative. Geneva: WHO, 2006.

  17. Encuesta Nacional de Adicciones (ENA 2002). Tabaco, alcohol y otras drogas. México: Secretaría de Salud-Consejo Nacional Contra las Adicciones, 2003.

  18. Dirección General de Epidemiología, Secretaría de Salud. Comunicación personal. México: Dirección General de Epidemiología, 2007.

  19. Benowitz N. Pharmacological aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-1330.

  20. Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence. Varenicline. Int J Clin Pract 2006;60(5):571-576.

  21. Ponciano RG. Adicción a la nicotina y tratamientos farmacológicos para la cesación del tabaquismo. Gac Fac Med UNAM 2001;Diciembre:14-15.

  22. The American Psychiatric Association. Diagnostic and Statistic Manual of Mental Dissorders. 4th edition. DSMIV. Washington DC: American Psychiatric Association, 1994.

  23. The Tobacco Use and Dependence Clinical Practice Guideline Panel Staff and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence: A US public health service report. JAMA 2000;283:3244-3254.

  24. Lerman C , Berrettini W. Treating tobacco dependence. State of the science and new directions. J Clin Oncol 2005;23(2):311-323.

  25. Jorenby ED, Leischow JS, Nides M, Rennard S, Jhonston AJ, Hughes RA, et al. A controlled trial of sustained release bupropion, a nicotine patch or both for smoking cessation. N Engl J Med 1999;340:685-691.

  26. Gonzales D, Rennard SI, Nides M, Oncken Ch, Azoulay S, Billing BC et al. Varenicline, an _4_2 nicotinic acetylcholine receptor partial agonist vs sustained release Bupropion and placebo for smoking cessation. A randomized controlled trial. JAMA 2006;296(1):47-55.

  27. Tonstad S, Tonnesen P, Hajek P, Williams EK, Billing BC, Reeves K et al. Effect of maintenance therapy with Varenicline on smoking cessation. A randomized controlled trial. JAMA 2006;296(1):64-71.

  28. Ponciano RG, Morales RA. Manual para el tratamiento integral del tabaquismo. México: Trillas, 2007. Documento no publicado.

  29. Guiza CVM, Quintanilla BJ, Lovaco SM, Torres AA, Ponciano RG, Morales RA. Clínicas contra el tabaquismo en México. Primer Informe sobre el combate al tabaquismo. En: Valdés-Salgado R, Lazcano-Ponce EC, Hernández-Ávila M. Primer informe sobre el combate al tabaquismo. México ante el Convenio Marco para el Control del Tabaco. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2005:223-233.

  30. Sansores RH, Ramírez VA, Pérez PR, Regalado PJ, Guisa CM, Quintanilla BJ et al. Tratamientos y terapias contra el tabaquismo disponibles en México. En: Valdés-Salgado R, Lazcano-Ponce EC, Hernández-Ávila M. Primer informe sobre el combate al tabaquismo. México ante el Convenio Marco para el Control del Tabaco. Cuernavaca, Morelos: Instituto Nacional de Salud Pública, 2005:235-247.

  31. Ponciano RG , Morales RA. Servicios de tratamiento para mujeres en la clínica para dejar de fumar de la Facultad de Medicina de la UNAM. En: Tabaco y Mujeres. México: Centros de Integración Juvenil AC, 2006:95-120.

  32. Mendoza MA, García MA, Cañedo DM. Resultados a 12 meses de un programa para dejar de fumar de tipo cognitivo-conductual y terapia farmacológica de apoyo. Neumol Cir Torax 2002;61(2):23-26.

  33. Sansores MRH, Córdoba PP, Espinosa MM, Herrera KL, Ramírez VA, Martínez RL et al. Evaluación del programa cognitivo-conductual para dejar de fumar del Instituto Nacional de Enfermedades Respiratorias. Rev Inst Nal Enf Resp Mex 1996;21(1): 29-35.

  34. Solano RS, Jiménez RCA. Historia clínica del tabaquismo. Prev Tabaquismo 2000;2(1):35-44.

  35. Marlatt GA, Gordon JR. Determinants of relapse. Implications for the maintenance of behaviour change. En: Davidson, Davidson, eds. Behavioral medicine: changing health lifestyles. New York: Brunner Mazel, 1980.

  36. Gorski TT, Miller M. Las fases y las señales de alerta de recaída. Missouri: Herald House/Independence Press, 1994.

  37. Ponciano RG, Hernández V, Salinas E, Rosas I. Urinary cotinine as a biomarker of exposure to environmental tobacco smoke in Mexican population. Am J Respir Crit Care Med 1997;153(4):702.

  38. National Research Council and Committee on Biological Markers. Biological markers in environmental health research. Env Health Perspect 1986;64:3-9.

  39. Fagerström OK. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors 1978;3:235-241.

  40. Fiore MC, Bailey WC, Cohen SC. Smoking cessation. Clinical practice guideline No 18. Rockville (MD): US Department of Health and Human Services, Public Health Service, Agency for Health and Care Policy and Research, 1996; AQHCPR Publication No 96-0692.

  41. Maxwell PL. Formal smoking cessation programs. Which ones are good? J Respir Dis 1998;19(8A):S50-S55.

  42. Valdés-Salgado R, Micher JM, Hernández L, Hernández M, Hernández AM. Tendencias del consumo de tabaco entre alumnos de nuevo ingreso a la Universidad Nacional Autónoma de México, 1989 a 1998. Salud Publica Mex 2002;44 suppl I:S44-S53.

  43. Centers for Disease Control and Prevention. Tobacco use among high school students- United States. 1997. MMWR 1998;47(12):229-233.

  44. Brownson RC, Jackson-Thompson J, Wilkerson JC, Davis JR, Owens NW, Fisher EB. Demographic and socio-economic differences in beliefs about the health effects of smoking. Am J Publ Health 1992;82(1):99-103.

  45. Sansores MRH, Regalado PJ, Giraldo BG, Prado GJA, Aguilar SC, Rubio MH et al. Guías mexicanas para el tratamiento del tabaquismo. Un consenso nacional de expertos. Neumol Cir Torax 2005;64(S2):S83-S112.

  46. Schwartz JL. Review and evaluation of smoking cessation methods: the US and Canada, 1978-1985. Bethesda: Division of Cancer Prevention and Control, National Cancer Institute, Public Health Service, 1987; NIH Publication 87:2940.

  47. West DW, Graham S, Swanson M, Wilkinson G. Five year follow-up of a smoking withdrawal clinic population. Am J Public Health 1977;67(6): 536-544.

  48. American Cancer Society. Guide to quitting smoking. [Consultado el 2 de abril, 2007]. Disponible en: http://www.cancer.org.

  49. Roales-Nieto GJ, Calero GDM. Tratamiento del tabaquismo. Madrid: Interamericana-Mc Graw-Hill, 1994.

  50. García BA, Abella PF. Tratamiento grupal del tabaquismo. En: Calvo FJR, López CA, eds. El Tabaquismo. España: Universidad de Palmas de Gran Canaria, 2003:557-585.

  51. Evans N, Farkas A, Gilpin E. Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J Nat Cancer Inst 1995;87(20):1538-1545.

  52. Diario Oficial de la Federación. NOM-028-SSA2-1999, para la prevención, tratamiento y control de las adicciones. 15 de septiembre del 2000. 1ª Sec.:44-60.

  53. Mejores prácticas en la prestación de servicios para dejar de fumar. Actualización profesional en salud. México: Consejo Nacional Contra las Adicciones, 2003.




2020     |     www.medigraphic.com